We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Dogbeda F. Mackenzie
Dogbeda F. Mackenzie
Products
PRODUCTS
Neilmed Pharmaceuticals, Inc.
Dogbeda F. Mackenzie
Price:
$117.00
View
Levlad, LLC
Dogbeda F. Mackenzie
Price:
$117.00
View
Gilead Sciences, Inc.
James Arnett
,
Uttaniti Limchumroon
,
Jacob G. Lutz
, and
Dogbeda F. Mackenzie
Price:
$117.00
View
Custom Research Labs, Inc.
Dogbeda F. Mackenzie
and
Jeffrey P. Raimondi
Price:
$117.00
View
Cosmetic Enterprises, Ltd
Dogbeda F. Mackenzie
,
Jeffrey P. Raimondi
, and
Khoa Nathan V. Tran
Price:
$117.00
View
Brenntag Pacific, Inc.
Dogbeda F. Mackenzie
Price:
$117.00
View
Cosmetic Group USA, Inc.
Kouros Kangarli
and
Dogbeda F. Mackenzie
Price:
$117.00
View
Upcoming Events
07
Dec
Proactive Supplier Management Using Quality Agreements
13
Dec
FDA Inspection Overhaul: How Things Have Changed in 2023
14
Apr
MAGI 2024: The Clinical Research Conference
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
FDA Laboratory-Developed Tests Proposal Comments Pour In by Thousands
Healthcare Titans Expand Their Portfolios in Acquisition Deals
Ups and Downs of Gene Therapy Weighed by FDA’s Marks
Device Manufacturers Pressed by Europe’s MDCG to Get Certified ASAP
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
